MedTrace Logo

Clinical Evaluation of dCELL® Meniscus for Partial Replacement of the Meniscus

NCT02270905 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2018-11-20

No results posted yet for this study

Summary

The safety and performance of dCELL® Meniscus will be evaluated in 60 patients after partial replacement of the native medial or lateral meniscus with the investigational product.

Conditions

  • Knee Injuries

Interventions

DEVICE

dCELL® Meniscus

decellularised porcine xenograft

Sponsors & Collaborators

  • Tissue Regenix Ltd

    lead INDUSTRY

Principal Investigators

  • David Houlihan-Burne · The Hillingdon Hospitals NHS Foundation Trust

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Poland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02270905 on ClinicalTrials.gov